St Jude Begins Major Lead Assessment Study
This article was originally published in The Gray Sheet
You may also be interested in...
News In Brief
AdvaMed presents CEO survey to FDA. Former ArthoCare exec pleads guilty to securities fraud charges from DOJ. CMS lists teaching hospitals that qualify for inclusion in company’s physician payment sunshine disclosure requirements. More news.
Research In Brief
Data preview for Heart Rhythm Society conference in Denver this week. More research news.
Challenges With ICD Leads Are Under Control, St. Jude Tells Investors
The company was prepared for FDA’s recent warning letter, executives said on an earnings call. But the scrutiny is not over, analysts suggest.